acquired
Stage
1
Investors
About
Lophius Biosciences develops immune diagnostic systems using T cell-based research tools and proprietary technologies to measure cell-mediated immunity for transplantation, infectious, and autoimmune disease management.
Explore Lophius Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.